Dan W. Gladney, Director at ReShape Lifesciences Inc. (RSLS), sold 200,000 shares at $2.99 ($598K) on 2021-09-10, disclosed to the SEC on 2021-09-17.
Open-market sale of $598k RSLS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |